Allspring Global Investments Holdings, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$2,357
+63.3%
146
+508.3%
0.00%
Q1 2023$1,443
-18.0%
240.0%0.00%
Q4 2022$1,760
+76.0%
240.0%0.00%
Q3 2022$1,0000.0%240.0%0.00%
Q2 2022$1,000240.00%
Other shareholders
NOVOCURE LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$39,681,00020.12%
HARTLINE INVESTMENT CORP/ 330,672$27,866,0005.97%
MORGAN JESS S & CO INC 52,889$4,457,0004.37%
Darsana Capital Partners LP 1,350,000$113,765,0003.88%
Rhenman & Partners Asset Management AB 350,000$29,495,0003.23%
COURAGE CAPITAL MANAGEMENT LLC 10,000$843,0002.55%
Taylor Frigon Capital Management LLC 38,073$3,208,0002.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,500$2,991,0001.08%
Granite Investment Partners, LLC 261,315$22,021,0001.04%
Nicholas Investment Partners, LP 85,835$7,233,0000.74%
View complete list of NOVOCURE LTD shareholders